A powerful new technology to identify HIV inhibitors

Providing long-term HIV treatment for over 33 million infected individuals worldwide requires the continuous development of new HIV therapies. Virologists at the Helmholtz Zentrum Munchen have developed a cell-based assay system for easy, reliable identification of HIV inhibitors. This new technology can be used to screen large collections of well-characterized reagents as well as raw extracts of biological specimens. The assay system is described in detail in the current issue of Antimicrobial Agents and Chemotherapy.

Read the whole article on Physorg

More from Physorg